EUVIMEDEUVIMED entdecken
Crossref

Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations

Mahmoud M Bendary iD, Arwa R Elmanakhly, Farag M Mosallam, Noaf Abdullah N Alblwi, Rasha A Mosbah, Walaa A Alshareef, Heba M R M Selim, Majid Alhomrani, Abdulhakeem S Alamri, Nesreen A Safwat, Ahmed M E Hamdan iD, Rana Elshimy

Helicobacter · 2024-07 · 29 (4)

DOI: 10.1111/hel.13110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, online erschienen am 12.07.2024. Verfasst von Mahmoud M Bendary und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said, Egypt. Hauptthemen laut MEDLINE: Azithromycin, Molecular Docking Simulation, Anti-Bacterial Agents, Biofilms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial‐resistant Helicobacter pylori ( H. pylori ) poses a significant public health concern, especially given the limited therapeutic options for azithromycin‐resistant strains. Hence, there is a necessity for new studies to reconsider the use of azithromycin, which has diminished in effectiveness against numerous strains. Thus, we aimed to augment azithromycin's anti‐ Helicobacter properties by combining it with curcumin in different formulations, including curcumin in clove oil, curcumin nano‐gold emulsion, and curcumin nanoemulsion.

Methods

The antimicrobial activities of the investigated compounds, both individually and in combination with other anti‐ Helicobacter drugs, were evaluated. Their antibiofilm and anti‐virulence properties were assessed using both phenotypic and genotypic methods, alongside molecular docking studies. Our findings were further validated through mouse protection assays and histopathological analysis.

Results

We observed high anti‐ Helicobacter activities of curcumin, especially curcumin nanoemulsion. A synergistic effect was detected between curcumin nanoemulsion and azithromycin with fraction inhibitory concentration index (FICI) values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinMolecular Docking SimulationAnti-Bacterial AgentsBiofilmsCurcuminHelicobacter InfectionsAnimalsMiceHelicobacter pyloriMicrobial Sensitivity TestsDrug SynergismBiological ProductsVirulenceFemale

Stichwörter der Autor:innen

H. pyloriFICIanti‐Helicobacteranti‐biofilmanti‐virulencecurcumin nanoemulsion

Substanzen

AzithromycinAnti-Bacterial AgentsCurcuminBiological Products

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Port Said University, Port Said, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Modern University of Technology and Information, Cairo, Egypt.
  • Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt.
  • Al Hadithah General Hospital Al-Qurayyat, Al Hadithah, Saudi Arabia.
  • Infection Control Unit, Zagazig University Hospital, Zagazig, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, 6th October University, Giza, Egypt.

ORCID-Profile: Mahmoud M Bendary, Ahmed M E Hamdan

Zitieren

APA

Bendary, M. M., Elmanakhly, A. R., Mosallam, F. M., Alblwi, N. A. N., Mosbah, R. A., Alshareef, W. A., Selim, H. M. R. M., Alhomrani, M., Alamri, A. S., Safwat, N. A., Hamdan, A. M. E., & Elshimy, R. (2024). Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations. Helicobacter, 29(4). https://doi.org/10.1111/hel.13110

Vancouver

Bendary MM, Elmanakhly AR, Mosallam FM, Alblwi NAN, Mosbah RA, Alshareef WA, et al. Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations. Helicobacter. 2024;29(4). doi:10.1111/hel.13110

BibTeX
@article{Bendary2024,
  author = {Bendary, Mahmoud M and Elmanakhly, Arwa R and Mosallam, Farag M and Alblwi, Noaf Abdullah N and Mosbah, Rasha A and Alshareef, Walaa A and Selim, Heba M R M and Alhomrani, Majid and Alamri, Abdulhakeem S and Safwat, Nesreen A and Hamdan, Ahmed M E and Elshimy, Rana},
  title = {Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations},
  journal = {Helicobacter},
  year = {2024},
  volume = {29},
  number = {4},
  doi = {10.1111/hel.13110}
}
Kostenlos starten →